iEFs inhibit EGFR phosphorylation in EGF-treated cancer cells thereby altering actin cytoskeleton structure and critical processes involved in cell motility—a potential mechanism explaining the observed hindrance of cancer cell motility by iEFs. The gene discussed is EGFR; the disease is cancer.